HAHaci Hasan Abuoglu

Haci Hasan Abuoglu

*This is an algorithmically generated author record based on publicly available information.

Haci Hasan Abuoglu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anorektal malign melanom: Bir olgu sunumu ve tedavi seçenekleri

    by Hacı Hasan ABUOĞLU, Mehmet Gençtürk, Mehmet Kamil Yildiz, Onur İlhan, Mehmet Gülmez, Kübra Kaytaz, Selvinaz Özkara

    Anorectal malignant melanoma (AMM) is a rare malignant disease with a poor prognosis. This disease is often confused with hemorrhoids. The most common site of malignant melanoma following skin and eye involvement is the anorectal region. This is the most commonly involved site in the gastrointestinal tract. We report the case of a 67-year-old patient with lower gastrointestinal hemorrhage for 4 months and hemorrhoid treatment for 2 months. The imaging revealed no distant metastasis but histopathologically, lymph node metastasis and invasion of surrounding tissues. Laparoscopic abdominoperineal resection (APR) was performed.

  • Association Between Onychomycosis and Foot Ulcers in Patients with Diabetes Mellitus

    by Haci Hasan Abuoglu, Emre Gunay, Sevil Ozkan, Hakan Uzunoglu, Riza Adaleti̇, Cebrail Akyuz, Bulent Kaya

    Objective: Diabetes mellitus (DM) is associated with many serious health complications such as diabetic foot ulcer (DFU). Onychomycosis increases the risk for foot disorders and limb amputation in DM patients, and if untreated, can result in tissue degradation and DFU. Therefore, this study aimed to determine the association between the incidences of onychomycosis and DFU. Methods: This study included 40 DM patients with DFU (study group) and 40 DM patients without FU (control group). Samples were obtained from the most affected part of the nail. The deep-nail plaque of the right toe was preferred in patients with normal toenail appearance. In addition, mycological examinations were conducted. Values of p<0.01 were considered as significant. Results: No significant difference was observed between the two groups with respect to age, sex, and hemoglobin A1c levels (p<0.01). However, the incidence of onychomycosis and use of insulin were significantly higher in the study group than in the control group (p<0.01 and p<0.001, respectively). Conclusion: Onychomycosis might be associated with development of FU in patients with DM. By treating onychomycosis early, foot amputation can be prevented.

  • Open Access

    Effect of Genetic Factors on the Etiopathogenesis of Thrombosed Hemorrhoidal Disease

    by Haci Hasan Abuoğlu, Emre Gunay, Hakan Uzunoğlu

    The aim of this study is to investigate whether genetic factors known to increase thrombosis risk play a role in the etiopathogenesis of thrombosed hemorrhoidal disease. Methods: Genomic DNA from patients with thrombosed hemorrhoidal disease was analyzed for the presence of factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase C677T, and methylenetetrahydrofolate reductase A1298C mutations. Results: No significant differences were found in the allele frequencies of factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase C677T, and methylenetetrahydrofolate reductase A1298C mutations between patients with thrombosed hemorrhoidal disease and controls (p 0.05). Moreover, there were no significant differences in the genotype (heterozygous and homozygous mutations) of factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase C677T and A1298C mutations between patients with thrombosed hemorrhoidal disease and controls (p 0.05). Conclusions: Our findings indicate that mutations associated with venous thromboembolism do not play a role in the etiopathogenesis of thrombosed hemorrhoidal disease; however, several environmental, mechanical, and hemodynamic factors may contribute to the etiopathogenesis of hemorrhoidal disease.


  • A New Protocol for Venous Thromboembolism Prophylaxis in Bariatric Surgery

    by Hacı Hasan Abuoglu, M. A. Tolga Müftüoğlu, Mehmet Odabaşı

    Morbidly obese patients are at high risk for developing venous thromboembolism (VTE). The aim of this study was to evaluate the effect of a new VTE prophylaxis protocol (low dosage, low-molecular-weight heparin [LMWH]) with a pneumatic compression device (PCD) in patients undergoing bariatric surgery.